GlassScriptPhysician profile
Gunjan Narwani
NPI 1699062547
$1,244.96
in general payments reported to CMS, 2019-2025
18 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.66 · 2021: $165 · 2022: $171 · 2023: $149 · 2024: $411 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $356.94 | 2024-2025 | Inspire |
| Abbvie INC. | $206.33 | 2021-2025 | |
| Sk Life Science, INC. | $165.46 | 2024 | Xcopri |
| Medtronic, INC. | $84.54 | 2023-2025 | Percept PC Brainsense, Activa PC |
| Amgen INC. | $74.47 | 2021-2024 | Repatha |
| Dexcom, INC. | $57.07 | 2021-2022 | |
| Ucb, INC. | $55.64 | 2019-2022 | |
| Livanova USA, INC. | $41.75 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceuticals, INC. | $29.79 | 2021 | |
| Pfizer INC. | $29.49 | 2023 | |
| Abbott Laboratories | $22.72 | 2024 | Infinity |
| Novo Nordisk INC | $21.74 | 2022 | |
| Zoll Respicardia, INC. | $20.95 | 2023 | Remede System |
| Jazz Pharmaceuticals INC. | $20.50 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.86 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $15.78 | 2019 | |
| Radius Health, INC. | $13.99 | 2022 | |
| Lilly USA, LLC | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gunjan Narwani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.